Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Return on Sales (2017 - 2025)

Selectis Health's Return on Sales history spans 14 years, with the latest figure at 0.05% for Q3 2025.

  • For Q3 2025, Return on Sales rose 12.0% year-over-year to 0.05%; the TTM value through Sep 2025 reached 0.06%, up 15.0%, while the annual FY2024 figure was 0.12%, 18.0% up from the prior year.
  • Return on Sales for Q3 2025 was 0.05% at Selectis Health, up from 0.06% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.09% in Q2 2022 and bottomed at 0.4% in Q4 2023.
  • The 5-year median for Return on Sales is 0.14% (2024), against an average of 0.14%.
  • The largest annual shift saw Return on Sales plummeted -33bps in 2023 before it surged 36bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.19% in 2021, then decreased by -6bps to 0.21% in 2022, then crashed by -94bps to 0.4% in 2023, then surged by 89bps to 0.04% in 2024, then fell by -6bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Return on Sales are 0.05% (Q3 2025), 0.06% (Q2 2025), and 0.09% (Q1 2025).